Mayfair Advisory Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,164
| Closed | -$231K | – | 149 |
|
|
2024
Q1 | $231K | Buy |
2,164
+122
| +6% | +$13K | 0.17% | 124 |
|
|
2023
Q4 | $230K | Hold |
2,042
| – | – | 0.2% | 112 |
|
|
2023
Q3 | $213K | Hold |
2,042
| – | – | 0.21% | 114 |
|
|
2023
Q2 | $243K | Hold |
2,042
| – | – | 0.24% | 99 |
|
|
2023
Q1 | $321K | Buy |
2,042
+50
| +3% | +$7.86K | 0.35% | 73 |
|
|
2022
Q4 | $366K | Buy |
1,992
+300
| +18% | +$55.2K | 0.47% | 61 |
|
|
2022
Q3 | $205K | Hold |
1,692
| – | – | 0.29% | 104 |
|
|
2022
Q2 | $278K | Buy |
+1,692
| New | +$278K | 0.37% | 83 |
|